The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future

Eur J Nucl Med Mol Imaging. 2024 May 13. doi: 10.1007/s00259-024-06758-y. Online ahead of print.

Author

Elif Hindié^{1

2

3}

Affiliations

¹ Service de Médecine Nucléaire, CHU de Bordeaux, Université de Bordeaux, Talence, F-33400, France. elif.hindie@chu-bordeaux.fr.
² Institut Universitaire de France, 1 rue Descartes, Paris cedex 05, 75231, France. elif.hindie@chu-bordeaux.fr.
³ Nuclear Medicine Department, University Hospitals of Bordeaux, Pessac, 33604, France. elif.hindie@chu-bordeaux.fr.

PMID: 38735885
DOI: 10.1007/s00259-024-06758-y

No abstract available

Keywords: Breast cancer; FDG-PET/CT; Neoadjuvant therapy; Response assessment; Staging.

Publication types

Editorial